Publicação científica trimestral do CREMERJ - volume 2 - número 2 - 2023

53 Med. Ciên. e Arte , Rio de Janeiro, v.2, n.2, p.42-54, abr-jun 2023 Esteatose Pancreática José Galvão-Alves e Bruna Cerbino de Souza 18. Lee JS, Kim SH, Jun DW et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009; 15: 1869-1875. 19. Al-Haddad M et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38, 672-675 (2009). 20. Schneider K, Harms K & Fendel H. The increased echogenicity of the pancreas in infants and children: the white pancreas. Eur. J. Pediatr. 146, 508-511 (1987). 21. Shawker TH., Linzer M & Hubbard VS. Chronic pancreatitis: the diagnostic significance of pancreatic size and echo amplitude. J. Ultrasound Med. 3, 267-272 (1984). 22. Worthen N J & Beabeau D. Normal pancreatic echogenicity: relation to age and body fat. AJR Am. J. Roentgenol. 139, 1095-1098 (1982). 23. Katz DS et al. Using CT to reveal fat containing abnormalities of the pancreas. AJR Am. J. Roentgenol. 172, 393-396 (1999). 24. Kim HJ et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. AJR Am. J. Roentgenol. 188, 429-432 (2007). 25. Kovanlikaya A et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr. Radiol. 35, 601-607 (2005). 26. Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J, Woodward T et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas. 2009;38(6):672-675. 27. Jones JS. Adult cystic fibrosis (mucoviscidosis). Fatty replacement of the pancreas in a woman aged 47 years. Br J Dis Chest. 1970;64(1):25-36. 28. Cubuk M, Arslan G, Ceken K, Ozkaynak C, Luyleci E. Schwachman-Diamond syndrome. A case report. Acta Radiol. 2000;41(6):627-628. 29. Lee JH, Bae SH, Yu JJ, Lee R, Yun YM, Song EY. A case of Shwachman-Diamond syndrome confirmed with genetic analysis in a Korean child. J Korean Med Sci. 2008;23(1):142-145. 30. Daentl DL, Frias JL, Gilbert EF, Opitz JM. The Johanson-Blizzard syndrome: case report and autopsy findings. Am J Med Genet. 1979;3(2):129-135. 31. Raeder H, Haldorsen IS, Ersland L, Gruner R, Taxt T, Sovik O, Molven A et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes. 2007;56(2):444-449. 32. Sasaki M, Nakanuma Y, Ando H. Lipomatous pseudohypertrophy of the pancreas in a patient with cirrhosis due to chronic hepatitis B. Pathol Int. 1998;48(7):566-568. 33. Diamond I, Vallbona C. Kwashiorkor in a North American white male. Pediatrics. 1960;25:248-257. 34. Pezzilli R, Calculli L. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes. 2014;5(4):415-419. 35. Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterol Res. 2016;9(6):87-91. 36. Sepe PS, Ohri A, Sanaka S et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 2011; 73:987-993. 37. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol 2013; 12: 77. 38. Musso G. et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 31, 562-568 (2008). 39. Zhang X, Cui Y, Fang L et al. Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas 2008; 37: e31-e38.